Illinois Tech Recognized in Cure Innovation Index for Translating Scientific Discoveries into Real-World Health Impact

CHICAGO-April 29, 2026-Illinois Institute of Technology (Illinois Tech) has been named a 2026 "Most Innovative Institution" in the inaugural 2026 Cure Innovation Index, a national benchmark assessing how effectively U.S. biomedical research institutions translate scientific discovery into real-world health impact.

Illinois Tech ranked #151 in the national university index and ranked #11 among the Index's top 20 "punching above their weight" institutions, a distinction recognizing translational research performance that exceeds expectations based on funding levels. The recognition highlights Illinois Tech's ability to generate outsized impact through scientific excellence, entrepreneurial culture, industry engagement, and focused execution.

"Recognition of Illinois Tech in the Cure Innovation Index reflects its leadership in translating scientific discovery into real-world impact," said Seema Kumar, CEO of Cure. "While traditional measures emphasize funding, publications, or patents, the Index sets a new standard by evaluating the full set of capabilities required to move innovation from concept to cure."

The Cure Innovation Index is the first national, data-driven platform designed to assess how effectively U.S. health sciences research institutions convert discovery into therapies, companies, and measurable health outcomes. The Index ranks the top 303 academic institutions, selected from more than 6,000 nationwide, and represents all 50 states, the District of Columbia, and Puerto Rico. The Index ranks 243 universities separately from 60 institutes and centers to reflect differences in their structures and missions.

"This recognition reflects Illinois Tech's strength in biomedical innovation and translational research," said Vice Provost for Research Jeff Terry. "Our faculty are advancing discoveries that address major health challenges-from cardiovascular disease and diabetes to optical implants, biochemistry, and infectious and metabolic disease-while doing so with the efficiency, creativity, and impact that define Illinois Tech."

Research Translation That Moves Beyond the Lab

The U.S. biomedical research ecosystem-anchored by academic institutions-has long been a global engine of innovation, driving the development of life-saving therapies and generating significant economic impact. Yet institutional performance has historically been measured by inputs and outputs, rather than by the ability to consistently translate discovery into impact.

"This distinction affirms Illinois Tech's commitment to advancing research that delivers tangible benefits for society," said Provost Elizabeth Hudson. "Across engineering, science, and computing, our faculty are accelerating the translation of discovery into real-world health solutions-ensuring that innovation does not stop at the lab, but reaches the communities and patients it is meant to serve."

Measuring the Path from Discovery to Impact

The Index evaluates institutions across 25 indicators within three core domains: Research Capabilities, Entrepreneurial Readiness, and Market Translation. Together, these dimensions capture the structural, cultural, and operational factors that enable institutions to move breakthroughs beyond the lab and into real-world application.

As part of the Index, Cure also assigns institutions to archetypes based on their scores across the three domains. These archetypes reflect the strategic areas where each institution has focused its translational research efforts and help illustrate the different pathways institutions take to move discovery toward impact.

Illinois Tech is classified within the Innovation Capacity Builders archetype, which identifies institutions that are actively engaged in the national health innovation ecosystem and have core research facilities and commercialization pathways in place. For Illinois Tech, the classification points to a strong foundation for translational growth, with opportunities to build distinctive strengths in focused areas of health technology and health sciences research, deepen commercialization capacity, and pursue targeted investments that can produce disproportionate impact.

Where Health Technology, Science, and Computing Converge

Illinois Tech's ranking is supported by a diverse portfolio of health-related research and innovation across the university, including:

• Health sciences and cardiovascular research: At the BioCAT-which was recently secured renewal by the National Institute of General Medical Sciences of the National Institutes of Health-faculty including Thomas Irving and Weikang Ma contribute to nationally significant work on heart muscle structure and function, helping deepen understanding of cardiovascular disease and muscle physiology.
• Diabetes technology and personalized health: Research by Ali Cinar in diabetes and biomedical systems engineering advances technologies and computational approaches for disease management and personalized health.
• Optical and neural implant technologies: The pioneering work of Philip R. Troyk on optical and neural implant technologies supports the development of next-generation devices that may restore or enhance biological function.
• Expanded health sciences infrastructure: The university's biomedical research enterprise has also expanded through new facilities and programs, including the Fulton Market biochemistry laboratory, which strengthens Illinois Tech's presence in Chicago's growing life sciences and health innovation district.

Together, these efforts reflect Illinois Tech's distinctive approach to health innovation: integrating code, machines, health, and science to address complex global challenges, while building the partnerships and research infrastructure needed to move discoveries closer to application.

Punching Above Its Weight

The Cure Innovation Index reveals a consistent pattern among institutions that lead in translational performance: they combine scientific excellence with strong commercialization infrastructure, deep industry engagement, and an embedded entrepreneurial culture.

Illinois Tech's ranking at #11 among the Index's top 20 "punching above their weight" institutions recognizes translational research performance that exceeds expectations relative to funding levels. The distinction highlights the university's strong strategy, research culture, and execution in advancing discoveries toward meaningful health outcomes.

"Being named among the institutions that are 'punching above their weight' is especially meaningful," said Terry. "It shows that Illinois Tech is producing translational outcomes at a level that outpaces expectations, demonstrating the strength of our faculty, students, partnerships, and research infrastructure."

Fast Facts

• 2026 "Most Innovative Institution" in the inaugural Cure Innovation Index
• #11 among the top 20 institutions "punching above their weight"
• #151 in the national university index
• Evaluated across Research Capabilities, Entrepreneurial Readiness, and Market Translation
• Classified as an Innovation Capacity Builder

About the Cure Innovation Index

Led by Cure, the Index was developed in collaboration with a multidisciplinary group of experts across academia, industry, and government, with analytical support from Deerfield Intelligence, a division of Deerfield Management Company. The methodology integrates validated data from more than a dozen federal and commercial sources, complemented by proprietary inputs from surveys of more than 3,000 researchers and industry leaders, as well as institutional audits assessing infrastructure, technology transfer capabilities, and translational programs. The full 2026 Cure Innovation Index results are available here: wewillcure.com/innovation-index

Photo: An artificial pancreas system developed by Professor Ali Cinar and his colleagues.

Illinois Institute of Technology

Based in the global metropolis of Chicago, Illinois Tech was born to liberate the power of collective difference to advance technology and innovation for all. It is the only tech-focused university in the city, and it stands at the crossroads of exploration and invention, advancing the future of Chicago and the world. It offers undergraduate and graduate degrees in engineering, computing, architecture, business, design, science and human sciences, and law. Illinois Tech students are guaranteed access to hands-on experiences, personalized mentorship, and job readiness through the university's one-of-a-kind Elevate program. Its graduates lead the state and much of the nation in economic prosperity. Its faculty and alumni built the Chicago skyline. And every day in the city's living lab, Illinois Tech fuels breakthroughs that change lives. Visit iit.edu.

Cure

Cure is the premier healthcare innovation ecosystem that provides knowledge, infrastructure and tools to accelerate progress toward cures. Headquartered in New York City, Cure convenes all key stakeholders for innovation across its physical and digital community. The campus houses flagship event venues and is home to healthcare organizations from idea stage to public companies. Cure members gain access to premium opportunities and curated connections. In 2026, The Cure Innovation Index was published, providing unmatched visibility into how research institutions translate breakthrough science into real-world health impact. Innovate with Cure at wewillcure.com. For more information, please visit wewillcure.com or contact [email protected]

Media contacts

Petra Kelly
Communications Director
Illinois Institute of Technology
Cell: 773.771.1064
[email protected]

Kevin Dollear
Communications Manager
Illinois Institute of Technology
Cell: 773.860.5712
[email protected]